Azaindazole compounds and methods of use

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 471/04 (2006.01) C07D 487/04 (2006.01)

Patent

CA 2612552

Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are generally aryl piperazine derivatives and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated diseases, and as controls in assays for the identification of competitive CCR1 antagonists.

Composés qui agissent en tant qu'antagonistes puissants du récepteur CCR1 et possèdent une activité anti-inflammatoire in vivo. Lesdits composés sont généralement des dérivés d'aryle pipérazine et sont utiles dans des compositions pharmaceutiques, dans des méthodes de traitement de maladies médiées par CCR1, et en tant que témoins dans des analyses pour l'identification d'antagonistes compétitifs de CCR1.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Azaindazole compounds and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Azaindazole compounds and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azaindazole compounds and methods of use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1512742

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.